SomnoMed® – The Leader in COAT™

At SomnoMed, we keep the patient at the center of our focus and know that successful treatment is much more than just the device. With our history of innovation, commitment to connecting physicians and dentists, SomnoMed is surrounding OSA patients with the products and services they need to return to enjoying their lives.

SomnoMed is the global leader in COAT (Continuous Open Airway Therapy) and provides clinically proven diagnostic and treatment options for sleep-related breathing disorders such as obstructive sleep apnea (OSA) and sleep bruxism.

Founded in Australia in 2004, SomnoMed Limited is now a publically listed company, trading in over 26 countries world wide.


Recent Press Releases

SomnoMed Launches New Products at AADSM
SomnoMed – Spain
SomnoMed Enters the UK

Appendix 3B_New Issue Announcement
Form 604_Notice of Change of interests of substantial holder